Aaron Kantoff Avalo Therapeutics, Inc. (AVTX) insider trading activity
Aaron Kantoff is Director of Avalo Therapeutics, Inc.. Currently has a direct ownership of 3,167 shares of AVTX, which is worth approximately $21,060. The most recent transaction as insider was on Mar 28, 2025, when has been sold 3,167 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.17K
0%
3M change
n/a
12M change
Total Value Held
$21,060
AARON KANTOFF Transaction History
Also insider at
AK
Aaron Kantoff
Director
Cheshire, X0